Rabeprazole - Wikipedia, the free encyclopedia
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole ...
http://en.wikipedia.org/wiki/Rabeprazole...
|
Rabeprazole: MedlinePlus Drug Information
Features information about dosage, usage, warnings, and side effects.
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a699060.htm...
|
Rabeprazole -- AHFS Consumer Medication Information -- NCBI Bookshelf
1 Jul 2003 ... Rabeprazole is used to treat conditions where the stomach produces too much acid , including ulcers, gastroesophageal reflux disease (GERD), ...
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=meds&part...
|
Rabeprazole: Drug Information Provided by Lexi-Comp: Merck Manual ...
A number of PPIs are available and include dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole. ...
http://www.merck.com/mmpe/lexicomp/rabeprazole.html...
|
Enantioselective disposition of rabeprazole in relation to CYP2C19 ...
Rabeprazole is metabolized to some extent by CYP2C19. The purpose of this study was to elucidate the pharmacokinetics of each rabeprazole enantiomer in ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885016/...
|
ACIPHEX(rabeprazole sodium) Delayed Release Tablets
Administration of rabeprazole to patients with mild to moderate liver impairment resulted in increased exposure and decreased elimination. ...
http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cf...
|
Systematic review: Rabeprazole-based therapies in Helicobacter ...
AIM: To perform a systematic review of the efficacy of rabeprazole-based therapies in Helicobacter pylori eradication, and to conduct a meta-analysis ...
http://www.ncbi.nlm.nih.gov/pubmed/12641497...
|
COMPARATIVE EFFICACY OF PARIET (RABEPRAZOLE): LESSONS FROM CLAIMS ...
Background: Pariet (rabeprazole) was introduced at a substantial price discount to existing, branded proton pump inhibitors (PPIs) in Canada. ...
http://gateway.nlm.nih.gov/MeetingAbstracts/103724965.html...
|
Rabeprazole, amoxycillin and low- or high-dose clarithromycin for ...
BACKGROUND: Rabeprazole sodium is a proton pump inhibitor. AIM: To evaluate the efficacy and safety of 1-week triple therapy with rabeprazole, ...
http://www.ncbi.nlm.nih.gov/pubmed/10930904...
|
Clinical Pharmacology & Therapeutics - Abstract of article ...
Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status* ...
http://www.nature.com/clpt/journal/v76/n4/abs/clpt2004492a.h...
|
